Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where P. C. Leung is active.

Publication


Featured researches published by P. C. Leung.


The American Journal of Chinese Medicine | 2006

Immunomodulatory Effects of a Traditional Chinese Medicine with Potential Antiviral Activity: A Self-Control Study

P. M. K. Poon; Chun-Kwok Wong; Kwok-Pui Fung; C. Y. S. Fong; E. L. Y. Wong; Joseph Lau; P. C. Leung; Stephen Kwok-Wing Tsui; David Chi Cheong Wan; Mary Miu Yee Waye; Shannon Wing Ngor Au; Ching-Po Lau; C. W. K. Lam

Traditional Chinese medicine (TCM) has been used for prevention and treatment of severe acute respiratory syndrome (SARS) in Hong Kong during the outbreak in spring 2003. We investigated the immunomodulating effects of an innovative TCM regimen derived from two herbal formulas (Sang Ju Yin and Yu Ping Feng San) for treating febrile diseases. Thirty-seven healthy volunteers were given the oral TCM regimen daily for 14 days. Peripheral venous blood samples were taken on days 0, 15 and 29 for hematology, biochemistry and immunology tests, including the measurement of blood lymphocyte subsets and plasma T-helper lymphocyte types 1 and 2 cytokines and receptor. After 3 months, 23 of the volunteers participated in a control study without TCM treatment for the same time course of blood tests. Two volunteers withdrew on day 2, due to headache and dizziness. All others remained well without any side effects. No participants showed significant changes in their blood test results, except that the T-lymphocyte CD4/CD8 ratio increased significantly from 1.31 +/- 0.50 (mean +/- SD) on day 0 to 1.41 +/- 0.63 on day 15 (p < 0.02), and reduced to 1.32 +/- 0.47 on day 29 (p < 0.05). In the control study, there were no changes in the CD4/CD8 ratio. The transient increase in CD4/CD8 ratio was likely due to the TCM intake. We postulate that the administration of the innovative TCM may have beneficial immunomodulatory effects for preventing viral infections including SARS.


Lupus | 2013

SLE disease per se contributes to deterioration in bone mineral density, microstructure and bone strength

X.-L. Tang; James F. Griffith; Ling Qin; V. W. Y. Hung; A. W. Kwok; Tracy Y. Zhu; Emily W. Kun; P. C. Leung; E. K. Li; L.-S. Tam

Objective The objective of this report is to assess the effect of systemic lupus erythematosus (SLE) disease itself on deterioration of bone mineral density (BMD), microstructure and bone strength. Method Thirty age-matched SLE patients on long-term glucocorticoids (GC) (SLE/GC), 30 SLE patients without GC (SLE/non-GC) and 60 healthy controls were examined. Areal BMD (aBMD) was measured by dual-energy X-ray absorptiometry. Bone geometry, volumetric BMD (vBMD), and architectural parameters at the nondominant distal radius were assessed by high-resolution peripheral quantitative computed tomography (HR-pQCT). Bone strength was estimated by HR-pQCT-based micro-finite element analysis. Results Adjusted for menopausal status and adjusted calcium level, when compared with controls, SLE/non-GC patients had significantly lower aBMD at femoral neck and total hip, and diminished radial total vBMD, cortical area, vBMD and thickness, respectively, by 8.3%, 8%, 2.7% and 9.2%, as well as significant compromised bone strength (stiffness, failure load and apparent modulus) by 8.3%, 9.1% and 9.5%, respectively. Similar alterations were also found in SLE/GC patients when compared to controls. In the premenopausal subgroup analysis, when compared with controls, total hip aBMD and radial cortical area were significantly lower in SLE/non-GC patients, and cortical area and thickness were significantly deficit in SLE/GC patients. However, no significant difference in any bone variables was present between SLE/GC and SLE/non-GC patients in the entire cohort or in the premenopausal subgroup. Conclusion SLE disease per se contributes to the deterioration in bone density, cortical microstructure and bone strength. This might help to explain the considerably higher fracture risk seen in SLE patients.


Biochemical and Biophysical Research Communications | 2010

Epigenetic regulation of neonatal cardiomyocytes differentiation.

Cecy Ying-Chuck Kou; Samantha Lai-Yee Lau; Ka-Wing Au; P. C. Leung; Stephen Siu Chung Chim; Kwok-Pui Fung; Mary Miu Yee Waye; Stephen Kwok-Wing Tsui

The relationship between DNA methylation, histone modifications and terminal differentiation in cardiomyocytes was investigated in this study. The upregulation of methylation-related proteins, including DNA methyltransferase (DNMT) 1, methyl-CpG binding domain proteins 1, 2 and 3, and the increase in global methylation during rat neonatal heart development were observed. Moreover, an increase in DNA synthesis and a delay in differentiation were found in 5-azacytidine (5-azaC)-treated cardiomyocytes. Increase in acetylation of H3-K9, H4-K5, H4-K8 and methylation of H3-K4 suggested a more accessible chromatin structure in 5-azaC-treated cells. Furthermore, methyl-CpG-binding protein 2 was found to be upregulated in differentiated cardiomyocytes. Overexpression of this protein resulted in an increase of global methylation levels. Therefore, we suggest that a hypermethylated genome and a more compact chromatin structure are formed during terminal differentiation of cardiomyocytes.


Journal of Bone and Joint Surgery-british Volume | 2000

Vascularised bone grafting for fibrous dysplasia of the upper limb

S. M. Kumta; P. C. Leung; James F. Griffith; J. Kew; Louis T. C. Chow

We describe our experience with vascularised bone grafting for the treatment of fibrous dysplasia of the upper limb in eight patients, five men and three women, aged between 17 and 36 years. The site was in the humerus in six and the radius in two. Persistent pain, progression of the lesion and pathological fracture with delayed union were the indications for surgical intervention. We used a vascularised fibular graft after curettage of the lesion. Function and radiological progress were serially monitored. Early radiological union of the graft occurred at periods ranging from 8 to 14 weeks. The mean period for reconstitution of the diameter of the bone was 14 months (12 to 18) predominantly through inductive formation of bone around the vascularised graft, which was a prominent feature in all patients. There were no recurrences and none of the grafts sustained a fracture or failed to unite. After operation function was excellent in three patients and good in five. Vascularised bone grafts provide a safe and reliable means of ensuring good continuity of bone with little risk of recurrence and failure.


Journal of Ethnopharmacology | 2012

Mechanisms of the cerebral vasodilator actions of isoflavonoids of Gegen on rat isolated basilar artery.

Y. Deng; E.S.K. Ng; John H.K. Yeung; Yiu Wa Kwan; Ching-Po Lau; Johnny Chi-Man Koon; Lin Li Zhou; Zhong Zuo; P. C. Leung; Kwok-Pui Fung; Francis F.Y. Lam

ETHNOPHARMACOLOGICAL RELEVANCE Gegen (root of Pueraria lobata) is used in traditional Chinese medicine for treatment of cardiovascular diseases. In this study, the relaxant actions of three of its isoflavonoids; puerarin, daidzein, and daidzin, were investigated on rat-isolated cerebral basilar artery. MATERIALS AND METHODS Rat basilar artery rings were precontracted with 100 nM U46619. Involvement of endothelium-dependent mechanisms was investigated by mechanical removal of the endothelium and inhibitors of nitric oxide synthase (NOS) and cyclooxygenase (COX) enzymes. Adenylyl cyclase- and guanylyl cyclase-dependent pathways were investigated using their respective inhibitors 9-(tetrahydro-2-furanyl)-9H-purine-6-amine (SQ22536) and 1H-[1,2,4]oxadiazolo [4,3-[alpha]]-quinoxalin-1-one (ODQ). K(+) channels were investigated by pretreatment of the artery rings with various K(+) channel inhibitors, and Ca(2+) channels were investigated in artery rings incubated with Ca(2+)-free buffer and primed with 100 nM U46619 for 5 min prior to adding CaCl(2) to elicit contraction. RESULTS Puerarin, daidzein, and daidzin produced concentration-dependent relaxation of the artery rings with concentration that produced 50% inhibition (IC(50)) of 304 ± 49 μM, 20 ± 7 μM, and 140 ± 21 μM, respectively. Removal of the endothelium produced no change on their vasorelaxant responses except the maximum response (I(max)) to puerarin was inhibited by 28%. The NOS inhibitor N(G)-nitro-l-arginine methyl ester (L-NAME; 100 μM) also produced 45% inhibition on the puerarin-induced vasorelaxant response, but not the COX inhibitor flurbiprofen (10 μM). SQ22536 (100 μM) and ODQ (100μM) did not affect the vasodilator responses to puerarin, daidzein and daidzin, but glibenclamide (1μM), tetraethylammonium (TEA, 100mM) or a combination of K(+) channel inhibitors (100nM iberiotoxin+1mM 4-aminopyridine+100 μM barium chloride+1 μM glibenclamide+100mM TEA) reduced their I(max). The contractile response to CaCl(2) was attenuated by 61% and 34% in the presence of daidzein and daidzin, respectively, whereas, puerarin did not significantly affect the contraction. CONCLUSIONS The vasorelaxant action of daidzein and daidzin involved opening of K(+) channels and inhibition of Ca(2+) influx in the vascular smooth muscle cells. There is no evidence supporting involvement of endothelium-derived relaxing factors (EDRFs) in their actions. In contrast, puerarin produced vasodilatation via an endothelium-dependent mechanism involving nitric oxide production and an endothelium-independent pathway mediated by the opening of K(+) channels. The cerebral vasodilator activities of all these three isoflavonoids may be beneficial to patients with obstructive cerebrovascular diseases.


Journal of Orthopaedic Research | 2011

Pamidronate, farnesyl transferase, and geranylgeranyl transferase-I inhibitors affects cell proliferation, apoptosis, and OPG/RANKL mRNA expression in stromal cells of giant cell tumor of bone

Carol P.Y. Lau; Lin Huang; Stephen Kwok-Wing Tsui; Patrick K.S. Ng; P. C. Leung; Shekhar M. Kumta

Giant cell tumor (GCT) is the most common nonmalignant primary bone tumor reported in Hong Kong. It usually affects young adults between the ages of 20 and 40. This tumor is well known for its potential to recur following treatment. To date no effective adjuvant therapy exists for GCT. Our project aimed to study the effects of pamidronate (PAM), farnesyl transferase inhibitor (FTI‐277), geranylgeranyl transferase inhibitor (GGTI‐298), and their combinations on GCT stromal cells (SC). Individual treatment with PAM, FTI‐277, and GGTI‐298, inhibited the cell viability and proliferation of GCT SC in a dose‐dependent way. Combination of FTI‐277 with GGTI‐298 caused synergistic effects in reducing cell viability, and its combination index was 0.49, indicating a strong synergism. Moreover, the combination of FTI‐277 with GGTI‐298 synergistically enhanced cell apoptosis and activated caspase‐3/7, ‐8, and ‐9 activities. PAM induced cell‐cycle arrest at the S‐phase. The combination of PAM with GGTI‐298 significantly increased OPG/RANKL mRNA ratio and activated caspase‐3/7 activity. Our findings support that the combination of bisphosphonates with GGTIs or FTIs with GGTIs may be used as potential adjuvants in the treatment of GCT of bone.


Journal of Bone and Joint Surgery, American Volume | 1998

A technique for enhancing union of allograft to host bone

Shekhar M. Kumta; P. C. Leung; James F. Griffith; Derek J. Roebuck; Louis T. C. Chow; Chi Kong Li

The aim of limb-salvage surgery in malignant bone tumours in children is to restore function and eradicate local disease with as little morbidity as possible. Allografts are associated with a high rate of complications, particularly malunion at the allograft-host junction. We describe a simple technique which enhances union of allograft to host bone taking advantage of the discrepancy in size between the adult allograft and the childs bone. This involves lifting a flap of periosteum before resection from the host bone, which is then telescoped into the allograft medullary canal, which may require internal burring or splitting, for a distance of 1.5 to 2 cm and covering the bone junction with the periosteal flap. This is more stable than conventional end-to-end opposition. For each centimetre of telescoping the surface area available for bony union is increased more than three times. The periosteal flap also augments union. Additional surface fixation with a plate and screws is not necessary. We have used this technique in nine children, in eight of whom there was complete union at a mean of 16 weeks. Delayed union, associated with generalised limb osteoporosis, occurred in one. Early mobilisation, with weight-bearing by three weeks, was possible. There was only one fracture of the allograft.


Journal of Ethnopharmacology | 2011

The involvement of N-G,N-G-dimethyarginine dimethylhydrolase 1 in the proliferative effect of Astragali radix on cardiac cells

Cindy S.L. Law; P. C. Leung; Patrick K.S. Ng; Cecy Ying-Chuck Kou; Karen K.W. Au; Junwei Zhou; Stephen Kwok-Wing Tsui

AIM OF THE STUDY Astragali radix (AR) is a widely used traditional medicine in oriental countries for treating various diseases including cardiovascular disease (CVD). We investigated the effects of AR extracts on rat cardiomyocytes and H9C2 cardiac cells as well as identified many target genes that mediate the effect of AR. MATERIALS AND METHODS The effect of AR extracts on cell proliferation was assessed and cDNA microarray technique was used to analyse the differential gene expressions upon AR treatment in cardiac cells. One of the selected target genes was over-expressed to elucidate its role in cell proliferation. RESULTS AR was shown to promote the proliferation of neonatal rat cardiomyocytes and H9C2 cells. Results of cDNA microarray hybridization showed that N-G,N-G-dimethylarginine dimethylaminohydrolase 1 (DDAH1) gene was up-regulated in AR-treated H9C2 cells and the results were further confirmed by reverse transcription polymerase chain reaction. Over-expression of DDAH1 gene in H9C2 cells significantly enhances the cell proliferation. Moreover, a drastic drop of DDAH1 expression in rat ventricular myocardium was observed from day 3 to day 5 after birth, which is the critical transition of cardiomyocytes from hyperplastic to hypertrophic growth. CONCLUSIONS AR promotes cardiac cell proliferation and up-regulates the DDAH1, an enzyme that metabolized the endogenous nitric oxide (NO) synthase inhibitor. The effect of AR on the metabolism of NO deserves future investigation.


Phytomedicine | 2007

Pharmacological investigations of the anti-diabetic effect of Cortex Moutan and its active component paeonol.

C.H. Lau; Chung-Lap Chan; Yuet-Wa Chan; Kit-Man Lau; T.W. Lau; F.C. Lam; W.T. Law; Chun-Tao Che; P. C. Leung; Kwok-Pui Fung; Y.Y. Ho; Ching-Po Lau


Phytotherapy Research | 2007

Investigation of the effects of Chinese medicine on fibroblast viability: implications in wound healing

T.W. Lau; Yuet-Wa Chan; Ching Po Lau; Chung-Lap Chan; Ching-Po Lau; Kwok-Pui Fung; P. C. Leung; Y.Y. Ho

Collaboration


Dive into the P. C. Leung's collaboration.

Top Co-Authors

Avatar

Kwok-Pui Fung

The Chinese University of Hong Kong

View shared research outputs
Top Co-Authors

Avatar

James F. Griffith

The Chinese University of Hong Kong

View shared research outputs
Top Co-Authors

Avatar

Ching-Po Lau

The Chinese University of Hong Kong

View shared research outputs
Top Co-Authors

Avatar

Stephen Kwok-Wing Tsui

The Chinese University of Hong Kong

View shared research outputs
Top Co-Authors

Avatar

Chun-Kwok Wong

The Chinese University of Hong Kong

View shared research outputs
Top Co-Authors

Avatar

Shekhar M. Kumta

The Chinese University of Hong Kong

View shared research outputs
Top Co-Authors

Avatar

Cecy Ying-Chuck Kou

The Chinese University of Hong Kong

View shared research outputs
Top Co-Authors

Avatar

Chung-Lap Chan

The Chinese University of Hong Kong

View shared research outputs
Top Co-Authors

Avatar

Louis T. C. Chow

The Chinese University of Hong Kong

View shared research outputs
Top Co-Authors

Avatar

T.W. Lau

The Chinese University of Hong Kong

View shared research outputs
Researchain Logo
Decentralizing Knowledge